Latest News and Press Releases

PHILADELPHIA, May 19, 2023 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company developing therapeutic proteins and one-time AAV gene therapies for major chronic pet health conditions, today...

PHILADELPHIA, July 01, 2022 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company revolutionizing pet medicine by delivering a pipeline of monoclonal antibodies and one-time AAV gene therapies for...

Scout Bio’s research was selected for presentation at the American College of Veterinary Internal Medicine (ACVIM) ForumThree lectures will present Scout Bio’s technology, new areas of research, and...

PHILADELPHIA, June 09, 2022 (GLOBE NEWSWIRE) --  Scout Bio, a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies and monoclonal antibodies for...

Brings experience in managing global innovation portfolios and business development to Scout BioExecutive leadership experience across both animal and human health PHILADELPHIA, Feb. 18, 2022 ...

PHILADELPHIA, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company developing therapeutic proteins and one-time AAV gene therapies for major chronic pet health conditions, today...

Partnership agreement includes exclusive rights in animal health to novel viral vector capsid and expands additional option rights to novel capsidsNext-generation novel adeno-associated viral (AAV)...

PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company focused on one-time AAV gene therapies for major chronic pet health conditions, received top honors as the Best...

- First vectorized antibody gene therapy to be studied in pets- Strong initial in-species data support therapeutic profile of one-time gene therapy designed for long-term pain management- Novel...

- Proceeds to support advancing single injection Adeno-Associated Viral (AAV) vector therapeutics targeting chronic companion animal diseases including diabetes, pain, and anemia associated with...